This analysis focused on the chronic form of HAT caused by T. b. gambiense, as it contributes to the majority of disease burden. Information from the literature review, product development landscape, and stakeholder interviews was compiled to: - Identify use cases and understand current diagnostic practices and tools associated with each use case. - Analyze progress toward robust diagnostics for HAT across different biomarkers. - Develop recommendations for steps to improve the availability, access, and adoption of HAT diagnostic tools.